Cargando…

Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial

AIMS: Although heart failure (HF) with preserved ejection fraction (HFpEF) is a leading cause for hospitalization, its overall costs remain unclear. Therefore, we assessed the health care‐related costs of ambulatory HFpEF patients and the effect of spironolactone. METHODS AND RESULTS: The aldosteron...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hashemi, Djawid, Dettmann, Ludwig, Trippel, Tobias D., Holzendorf, Volker, Petutschnigg, Johannes, Wachter, Rolf, Hasenfuß, Gerd, Pieske, Burkert, Zapf, Antonia, Edelmann, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261555/ https://www.ncbi.nlm.nih.gov/pubmed/31984661 http://dx.doi.org/10.1002/ehf2.12606

Ejemplares similares

Plasma Biomarker Profiling in Heart Failure Patients with Preserved Ejection Fraction before and after Spironolactone Treatment: Results from the Aldo-DHF Trial
por: Schnelle, Moritz, et al.
Publicado: (2021)

Ghrelin and hormonal markers under exercise training in patients with heart failure with preserved ejection fraction: results from the Ex‐DHF pilot study
por: Trippel, Tobias Daniel, et al.
Publicado: (2016)

The diagnostic and prognostic value of galectin‐3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST‐CHF study
por: Trippel, Tobias Daniel, et al.
Publicado: (2021)

Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction
por: Nolte, Kathleen, et al.
Publicado: (2019)

ALDO-DHF & Paramount
por: ElGuindy, Ahmed M
Publicado: (2013)

Influence of baseline parameters on one‐year physical, mental, and health‐related quality of life in patients with heart failure and preserved ejection fraction
por: Fitz, Judith, et al.
Publicado: (2021)

Outcome assessment using estimation of left ventricular filling pressure in asymptomatic patients at risk for heart failure with preserved ejection fraction
por: Bobenko, Anna, et al.
Publicado: (2020)

Evaluation of the HFA‐PEFF Score: results from the prospective DIAST‐CHF cohort
por: Hashemi, Djawid, et al.
Publicado: (2022)

Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction
por: Bobenko, Anna, et al.
Publicado: (2017)

Saturated Fatty Acid Blood Levels and Cardiometabolic Phenotype in Patients with HFpEF: A Secondary Analysis of the Aldo-DHF Trial
por: Lechner, Katharina, et al.
Publicado: (2022)

Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trial
por: Lechner, Katharina, et al.
Publicado: (2021)

Longitudinal association between N-terminal B-type natriuretic peptide, anxiety and social support in patients with HFpEF: results from the multicentre randomized controlled Aldo-DHF trial
por: Wilke, Marieke R., et al.
Publicado: (2023)

Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction
por: Edelmann, Frank, et al.
Publicado: (2011)

Determinants of submaximal exercise capacity in patients at risk for heart failure with preserved ejection fraction—results from the DIAST‐CHF study
por: Stahrenberg, Raoul, et al.
Publicado: (2015)

Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial
por: Lechner, Katharina, et al.
Publicado: (2023)

The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction
por: Stahrenberg, Raoul, et al.
Publicado: (2010)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Left atrial function and maximal exercise capacity in heart failure with preserved and mid‐range ejection fraction
por: Maffeis, Caterina, et al.
Publicado: (2020)

Heterogeneous Metabolic Response to Exercise Training in Heart Failure with Preserved Ejection Fraction
por: Bahls, Martin, et al.
Publicado: (2019)

Multilayer myocardial strain improves the diagnosis of heart failure with preserved ejection fraction
por: Tanacli, Radu, et al.
Publicado: (2020)

Syncopes and clinical outcome in heart failure: results from prospective clinical study data in Germany
por: Hashemi, Djawid, et al.
Publicado: (2020)

Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure
por: Wachter, Rolf, et al.
Publicado: (2009)

Heart failure awareness survey in Germany: general knowledge on heart failure remains poor
por: Zelenak, Christine, et al.
Publicado: (2017)

Range Variability in CMR Feature Tracking Multilayer Strain across Different Stages of Heart Failure
por: Tanacli, Radu, et al.
Publicado: (2019)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

Single center experience of CMR findings after COVID-19 and after COVID-19-vaccination
por: Doeblin, Patrick, et al.
Publicado: (2022)

Reduced functional capacity is associated with the proportion of impaired myocardial deformation assessed in heart failure patients by CMR
por: Hashemi, Djawid, et al.
Publicado: (2023)

CMR detects decreased myocardial deformation in asymptomatic patients at risk for heart failure
por: Hashemi, Djawid, et al.
Publicado: (2023)

Iron Deficiency Impacts Diastolic Function, Aerobic Exercise Capacity, and Patient Phenotyping in Heart Failure With Preserved Ejection Fraction: A Subanalysis of the OptimEx-Clin Study
por: Gevaert, Andreas B., et al.
Publicado: (2022)

Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST‐CHF study
por: Eidizadeh, Abass, et al.
Publicado: (2022)

A short form of the General Self-Efficacy Scale (GSE-6): Development, psychometric properties and validity in an intercultural non-clinical sample and a sample of patients at risk for heart failure
por: Romppel, Matthias, et al.
Publicado: (2013)

Diastolic stress test echocardiography in patients with suspected heart failure with preserved ejection fraction: a pilot study
por: Belyavskiy, Evgeny, et al.
Publicado: (2018)

Incremental value of mineralocorticoid receptor antagonists in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan
por: Benini, Annachiara, et al.
Publicado: (2022)

Clinical Manifestations and Management of Dengue/DHF/DSS
por: Kalayanarooj, Siripen
Publicado: (2011)

Left ventricular longitudinal systolic function analysed by 2D speckle-tracking echocardiography in heart failure with preserved ejection fraction: a meta-analysis
por: Morris, Daniel Armando, et al.
Publicado: (2017)

Elevated Plasma C-Terminal Endothelin-1 Precursor Fragment Concentrations Are Associated with Less Anxiety in Patients with Cardiovascular Risk Factors. Results from the Observational DIAST-CHF Study
por: Meyer, Thomas, et al.
Publicado: (2015)

Effects of different exercise modalities on cardiac dysfunction in heart failure with preserved ejection fraction
por: Bode, David, et al.
Publicado: (2021)

Heterogeneous responses of systolic and diastolic left ventricular function to exercise in patients with heart failure and preserved ejection fraction
por: Kasner, Mario, et al.
Publicado: (2015)

Muscular changes in animal models of heart failure with preserved ejection fraction: what comes closest to the patient?
por: Goto, Keita, et al.
Publicado: (2020)

Treatment response to spironolactone in patients with heart failure with preserved ejection fraction: a machine learning-based analysis of two randomized controlled trials
por: Kresoja, Karl-Patrik, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cimjq71mmmn1k3dikq3aiadi51